Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/41602 |
Resumo: | Ministério da Saúde e CAPES |
id |
CRUZ_d4b8ff6c47ca77820e74dfdad13742b7 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/41602 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Carvalho, Viviane Karoline da SilvaSousa, Maria Sharmila Alina deBarreto, Jorge Otávio MaiaSilva, Everton Nunes da2020-06-10T13:42:57Z2020-06-10T13:42:57Z2019CARVALHO, Viviane Karoline da Silva et al. Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation. BMC Health Services Research, [London], v. 19, n. 762, p. 1-11, 2019.1472-6963https://www.arca.fiocruz.br/handle/icict/4160210.1186/s12913-019-4555-6Ministério da Saúde e CAPESUniversidade de Brasília. Brasília, DF, Brasil.Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.Fundação Oswaldo Cruz. Fiocruz Brasília. Brasília, DF, Brasil.Universidade de Brasília. Brasília, DF, Brasil.Background: Public engagement in health technology assessment (HTA) is increasing worldwide. There are several forms of public engagement and it is not always possible to determine which stakeholders participate in the HTA process and how they contribute. Our objective was to investigate which types of social representatives contributed to the public consultation on the incorporation of Trastuzumab for early-stage breast cancer treatment within the public health system in Brazil, held in 2012 by the National Committee for Health Technology Incorporation (CONITEC). Methods: A mixed methods approach was used to analyze social representativeness and the composition of the corpus from the public consultation, which consisted of 127 contributions. Three types of analysis were performed using IRaMuTeQ software: classic lexical analysis, descending hierarchical classification and specificities analysis. The contributions were clustered according to the main categories of discourse observed, into four social representation categories: 1) patient representation/advocacy; 2) pharmaceutical industry/advocacy; 3) healthcare professionals; and 4) individual contributions. Results: Category 1 contained words related to increased survival due to use of the drug and a low score for words pertaining to studies on Trastuzumab. The word “safety” obtained a positive score only in category 2, which was also the only category that exhibited a negative score for the word “risk”. Category 3 displayed the lowest scores for “diagnosis” and “safety”. The word “efficacy” had a negative score only in category 4. Conclusions: Each category exhibited different results for words related to health systems and to key concepts linked to HTA. Our analysis enabled the identification of the most prominent contributions for each category. Despite the promising results obtained, further research is needed to validate this software for use in analyzing public contributions.engBMC part of Springer NatureBreast NeoplasmsNeoplasm StagingTechnology Assessment, BiomedicalTrastuzumabCommunity ParticipationBrazilAnalytical methodsHealth technology assessment (HTA)Public consultationPublic engagementPublic opinionSocial participationTrastuzumabNeoplasias da MamaEstadiamento de NeoplasiasAvaliação da Tecnologia BiomédicaParticipação da ComunidadePublic engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultationinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83074https://www.arca.fiocruz.br/bitstream/icict/41602/1/license.txtd3e717dbb24bfc607ede047f44d29a0eMD51ORIGINALve_Viviane_Carvalho_etal.pdfve_Viviane_Carvalho_etal.pdfapplication/pdf1122933https://www.arca.fiocruz.br/bitstream/icict/41602/2/ve_Viviane_Carvalho_etal.pdf18b771602cc78498acb6ac5ebc304b4dMD52TEXTve_Viviane_Carvalho_etal.pdf.txtve_Viviane_Carvalho_etal.pdf.txtExtracted texttext/plain54684https://www.arca.fiocruz.br/bitstream/icict/41602/3/ve_Viviane_Carvalho_etal.pdf.txt8a8ae11ab8b46e52a4e5b55c4fe119d1MD53icict/416022020-12-10 21:39:19.23oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352020-12-11T00:39:19Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation |
title |
Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation |
spellingShingle |
Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation Carvalho, Viviane Karoline da Silva Breast Neoplasms Neoplasm Staging Technology Assessment, Biomedical Trastuzumab Community Participation Brazil Analytical methods Health technology assessment (HTA) Public consultation Public engagement Public opinion Social participation Trastuzumab Neoplasias da Mama Estadiamento de Neoplasias Avaliação da Tecnologia Biomédica Participação da Comunidade |
title_short |
Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation |
title_full |
Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation |
title_fullStr |
Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation |
title_full_unstemmed |
Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation |
title_sort |
Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation |
author |
Carvalho, Viviane Karoline da Silva |
author_facet |
Carvalho, Viviane Karoline da Silva Sousa, Maria Sharmila Alina de Barreto, Jorge Otávio Maia Silva, Everton Nunes da |
author_role |
author |
author2 |
Sousa, Maria Sharmila Alina de Barreto, Jorge Otávio Maia Silva, Everton Nunes da |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Carvalho, Viviane Karoline da Silva Sousa, Maria Sharmila Alina de Barreto, Jorge Otávio Maia Silva, Everton Nunes da |
dc.subject.mesh.pt_BR.fl_str_mv |
Breast Neoplasms Neoplasm Staging Technology Assessment, Biomedical Trastuzumab Community Participation Brazil |
topic |
Breast Neoplasms Neoplasm Staging Technology Assessment, Biomedical Trastuzumab Community Participation Brazil Analytical methods Health technology assessment (HTA) Public consultation Public engagement Public opinion Social participation Trastuzumab Neoplasias da Mama Estadiamento de Neoplasias Avaliação da Tecnologia Biomédica Participação da Comunidade |
dc.subject.en.pt_BR.fl_str_mv |
Analytical methods Health technology assessment (HTA) Public consultation Public engagement Public opinion Social participation |
dc.subject.decs.pt_BR.fl_str_mv |
Trastuzumab Neoplasias da Mama Estadiamento de Neoplasias Avaliação da Tecnologia Biomédica Participação da Comunidade |
description |
Ministério da Saúde e CAPES |
publishDate |
2019 |
dc.date.issued.fl_str_mv |
2019 |
dc.date.accessioned.fl_str_mv |
2020-06-10T13:42:57Z |
dc.date.available.fl_str_mv |
2020-06-10T13:42:57Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
CARVALHO, Viviane Karoline da Silva et al. Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation. BMC Health Services Research, [London], v. 19, n. 762, p. 1-11, 2019. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/41602 |
dc.identifier.issn.pt_BR.fl_str_mv |
1472-6963 |
dc.identifier.doi.none.fl_str_mv |
10.1186/s12913-019-4555-6 |
identifier_str_mv |
CARVALHO, Viviane Karoline da Silva et al. Public engagement in health technology assessment in Brazil: the case of the Trastuzumab public consultation. BMC Health Services Research, [London], v. 19, n. 762, p. 1-11, 2019. 1472-6963 10.1186/s12913-019-4555-6 |
url |
https://www.arca.fiocruz.br/handle/icict/41602 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
BMC part of Springer Nature |
publisher.none.fl_str_mv |
BMC part of Springer Nature |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/41602/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/41602/2/ve_Viviane_Carvalho_etal.pdf https://www.arca.fiocruz.br/bitstream/icict/41602/3/ve_Viviane_Carvalho_etal.pdf.txt |
bitstream.checksum.fl_str_mv |
d3e717dbb24bfc607ede047f44d29a0e 18b771602cc78498acb6ac5ebc304b4d 8a8ae11ab8b46e52a4e5b55c4fe119d1 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798325071673032704 |